Critical review of p38 MAP kinase inhibitors: a bioanalytical perspective

Philip Wong1, Faye Hsieh, Roger Pham

  • 1Department of Pharmacokinetics & Drug Metabolism, 1 Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA. pwong@amgen.com

Bioanalysis
|December 24, 2011
PubMed